{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T05:20:55Z","timestamp":1739596855709,"version":"3.37.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00120-024-02508-y","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:33:02Z","timestamp":1738611182000},"page":"120-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Funktionsst\u00f6rungen des unteren Harntrakts: Morbus Parkinson","Functional disorders of the lower urinary tract: Parkinson\u2019s disease"],"prefix":"10.1007","volume":"64","author":[{"given":"Stephanie C.","family":"Kn\u00fcpfer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"issue":"3","key":"2508_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1464-410X.2009.08371.x","volume":"103","author":"KS Coyne","year":"2009","unstructured":"Coyne\u00a0KS et\u00a0al (2009) The burden of lower urinary tract symptoms: evaluation the effect of LUTS on health-related quality of life, anxiety and depression: Epi LUTS. BJU Int 103(3):4","journal-title":"BJU Int"},{"key":"2508_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1464-410X.2005.05889.x","volume":"97","author":"DE Irwin","year":"2006","unstructured":"Irwin\u00a0DE et\u00a0al (2006) Impact of overactive blader symptoms on employment, social interactions and emotional well-being in six European contries. BJU Int 97:96","journal-title":"BJU Int"},{"key":"2508_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn2401","volume":"9","author":"CJ Fowler","year":"2008","unstructured":"Fowler\u00a0CJ et\u00a0al (2008) The neural control of micturition. Nat Rev Neurosci 9:453\u2013466","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"2508_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","volume":"14","author":"JN Panicker","year":"2015","unstructured":"Panicker\u00a0JN et\u00a0al (2015) Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol 14(7):720\u2013732","journal-title":"Lancet Neurol"},{"key":"2508_CR5","first-page":"33","volume-title":"Textbook of the Neurogenic","author":"N Yoshimura","year":"2016","unstructured":"Yoshimura\u00a0N et\u00a0al (2016) Integrated physiology of the lower urinary tract. In: Bladder, Corcos\u00a0J, Ginsberg\u00a0D, Karsenty\u00a0G (Hrsg) Textbook of the Neurogenic. CRC Press\u2014Taylor & Francis Group, S\u00a033\u201347"},{"key":"2508_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0090-4295(02)01544-3","volume":"59","author":"CJ Fowler","year":"2002","unstructured":"Fowler\u00a0CJ (2002) Bladder afferents and their role in the overactive bladder. Urology 59:37","journal-title":"Urology"},{"key":"2508_CR7","first-page":"1","volume-title":"Pelvic Organ Dysfunction in Neurological Disease: Clinical Management and","author":"D Griffiths","year":"2010","unstructured":"Griffiths\u00a0D et\u00a0al (2010) Neurological control of the bladder in health and disease. In: Rehabilitation, Fowler\u00a0C, Panicker\u00a0J, Emmanuel\u00a0A (Hrsg) Pelvic Organ Dysfunction in Neurological Disease: Clinical Management and. Cambridge University Press, Cambridge, UK, S\u00a01\u201324"},{"issue":"20","key":"2508_CR8","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1212\/WNL.0b013e3181fdabba","volume":"75","author":"EE Benarroch","year":"2010","unstructured":"Benarroch\u00a0EE et\u00a0al (2010) Neural control of the bladder: recent advances and neurologic implications. Neurology 75(20):1839\u20131846","journal-title":"Neurology"},{"issue":"4","key":"2508_CR9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.juro.2009.12.060","volume":"183","author":"A Kanai","year":"2010","unstructured":"Kanai\u00a0A et\u00a0al (2010) Bladder afferent signaling:recent findings. J\u00a0Urol 183(4):1288\u20131295","journal-title":"J Urol"},{"issue":"3","key":"2508_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pmr.2014.04.001","volume":"25","author":"S Kirshblum 3rd","year":"2014","unstructured":"Kirshblum\u00a0S\u00a03rd et\u00a0al (2014) Updates for the International Standards for Neurological Classification of Spinal Cord Injury. Phys Med Rehabil Clin N Am 25(3):505\u2013517, vii","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"2508_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60440-9","volume-title":"Neurogene Blasenfunktionsst\u00f6rung, Neurogene Sexualst\u00f6rung","author":"M St\u00f6hrer","year":"1997","unstructured":"St\u00f6hrer\u00a0M et\u00a0al (1997) Neurogene Blasenfunktionsst\u00f6rung, Neurogene Sexualst\u00f6rung. Springer, Berlin Heidelberg"},{"key":"2508_CR12","volume-title":"Diagnostik und Therapie von neurogenen Blasenst\u00f6rungen-Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"WH Jost","year":"2012","unstructured":"Jost\u00a0WH et\u00a0al (2012) Diagnostik und Therapie von neurogenen Blasenst\u00f6rungen-Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie, 5.\u00a0Aufl. Bd. 2014","edition":"5"},{"issue":"31\/32","key":"2508_CR13","first-page":"A-2113","volume":"91","author":"M St\u00f6hrer","year":"1994","unstructured":"St\u00f6hrer\u00a0M et\u00a0al (1994) Neurogene Blasenfunktionsst\u00f6rung aus urologischer Sicht. Dtsch \u00c4rztebl 91(31\/32):A-2113","journal-title":"Dtsch \u00c4rztebl"},{"key":"2508_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic\u00a0J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J\u00a0Neurol Neurosurg Psychiatry 79:368\u2013376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2508_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt\u00a0K et\u00a0al (2011) Epidemiology and etiology of Parkinson\u2019s disease: a\u00a0review of the evidence. Eur J Epidemiol 26(1):S1\u2013S58. https:\/\/doi.org\/10.1007\/s10654-011-9581-6","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"2508_CR16","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0022-5347(05)67048-6","volume":"164","author":"I Araki","year":"2000","unstructured":"Araki\u00a0I et\u00a0al (2000) Voiding dysfunction and Parkinsons\u2019s disease: urodynamic abnormalities and urinary symptoms. J\u00a0Urol 164(5):1640\u20131643","journal-title":"J Urol"},{"issue":"2-B","key":"2508_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1590\/S0004-282X2003000300007","volume":"61","author":"RN Campos-Sousa","year":"2003","unstructured":"Campos-Sousa\u00a0RN et\u00a0al (2003) Urinary symptoms in parkinson\u2019s disease. Prevalence and associated factors. Arq Neuropsiquiatr 61(2-B):359\u2013363","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"2508_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12894-016-0174-2","volume":"16","author":"SC Kn\u00fcpfer","year":"2016","unstructured":"Kn\u00fcpfer\u00a0SC et\u00a0al (2016) Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson\u2019s disease. BMC Urol 16(1):55","journal-title":"BMC Urol"},{"key":"2508_CR19","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/nau.20983","volume":"30","author":"MM Ragab","year":"2011","unstructured":"Ragab\u00a0MM et\u00a0al (2011) Ideopathic Parkinson\u2019s disease patients at the urologic clinic. Neurourol Urodyn 30:1258\u20131261","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"2508_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0022-5347(17)51929-1","volume":"129","author":"AJ Pavlakis","year":"1983","unstructured":"Pavlakis\u00a0AJ et\u00a0al (1983) Neurologic findings in Parkinson\u2019s disease. J\u00a0Urol 129(1):80\u201383","journal-title":"J Urol"},{"key":"2508_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.20844","volume":"21","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri\u00a0KR et\u00a0al (2006) International Multicenter Pilot Study of the First Comprehensive Self-Completed Non Motor Symptoms Questionnaire for Parkinson\u2019s Disease: The NMSQuest study. Mov Disord 21:916\u2013923","journal-title":"Mov Disord"},{"key":"2508_CR22","unstructured":"EAU Guideline Neuro-Urology. https:\/\/uroweb.org\/guideline\/neuro-urology\/"},{"issue":"2","key":"2508_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000054774","volume":"20","author":"R Lawrenson","year":"2001","unstructured":"Lawrenson\u00a0R et\u00a0al (2001) Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology 20(2):138\u2013143","journal-title":"Neuroepidemiology"},{"key":"2508_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0022-5347(17)52384-8","volume":"129","author":"EJ McGuire","year":"1983","unstructured":"McGuire\u00a0EJ et\u00a0al (1983) Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a\u00a0follow up study. J\u00a0Urol 129:823\u2013826","journal-title":"J Urol"},{"key":"2508_CR25","doi-asserted-by":"crossref","unstructured":"Tanagho\u00a0EA, Schmidt\u00a0RA (1992) Neurogene Blasenerkrankungen. In: Smiths Urologie. Berlin-Stuttgart, S\u00a036\u2013559","DOI":"10.1007\/978-3-642-76107-2_20"},{"key":"2508_CR26","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","volume":"148","author":"P Abrahams","year":"2006","unstructured":"Abrahams\u00a0P et\u00a0al (2006) Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148:565\u2013578","journal-title":"Br J Pharmacol"},{"key":"2508_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00005392-200102000-00032","volume":"165","author":"D Stasi","year":"2001","unstructured":"Stasi\u00a0D et\u00a0al (2001) Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standart anticholinergic regimens. J\u00a0Urol 165:491","journal-title":"J Urol"},{"issue":"1","key":"2508_CR28","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1002\/mds.22519","volume":"25","author":"R Sakakibara","year":"2010","unstructured":"Sakakibara\u00a0R et\u00a0al (2010) Genitourinary Dysfunction in Parkinon\u2019s Disease. Mov Disord 25(1):2010","journal-title":"Mov Disord"},{"issue":"12","key":"2508_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/ncpuro1251","volume":"5","author":"TM Kessler","year":"2008","unstructured":"Kessler\u00a0TM et\u00a0al (2008) Sacral neuromodulation for urinary retention. Nat Clin Pract Urol 5(12):657\u2013666","journal-title":"Nat Clin Pract Urol"},{"key":"2508_CR30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0022-5347(01)61761-0","volume":"161","author":"WW Leng","year":"1999","unstructured":"Leng\u00a0WW et\u00a0al (1999) Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J\u00a0Urol 161:758\u2013763","journal-title":"J Urol"},{"issue":"10","key":"2508_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s00120-006-1179-3","volume":"45","author":"Nyarangi-Dix","year":"2006","unstructured":"Nyarangi-Dix et\u00a0al (2006) Overactive bladder syndrome. Are there indications for surgical therapy? Urologe\u00a0A 45(10):1289\u20131290, 1292","journal-title":"Urologe A"},{"key":"2508_CR32","first-page":"3","volume-title":"History and current applications of botulinum toxin\u2014from poison to remedy","author":"M Naumann","year":"2003","unstructured":"Naumann\u00a0M et\u00a0al (2003) History and current applications of botulinum toxin\u2014from poison to remedy. Blackwell Science Ltd, S\u00a03\u20138"},{"issue":"2001","key":"2508_CR33","first-page":"261","volume":"72","author":"H G\u00f6bel","year":"2001","unstructured":"G\u00f6bel\u00a0H et\u00a0al (2001) Botulinum-Toxin in der Therapie von Kopfschmerzerkrankungen und perikranialen Schmerzsyndromen. Nervenarzt 72(2001):261\u2013274","journal-title":"Nervenarzt"},{"key":"2508_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","volume":"139","author":"DD Dykstra","year":"1988","unstructured":"Dykstra\u00a0DD et\u00a0al (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J\u00a0Urol 139:919\u2013922","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"2508_CR35","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch\u00a0B et\u00a0al (2000) Botulinum\u2014A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a\u00a0new alternative to antichilinergic drugs? Preliminary results. J\u00a0Urol 164(3 Pt 1):692\u2013697","journal-title":"J Urol"},{"issue":"4","key":"2508_CR36","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","volume":"60","author":"F Cruz","year":"2011","unstructured":"Cruz\u00a0F et\u00a0al (2011) Efficacy and savety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a\u00a0randomized, double-blin, placebo-controlled trial. Eur Urol 60(4):742\u2013750","journal-title":"Eur Urol"},{"issue":"6","key":"2508_CR37","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","volume":"187","author":"D Ginsberg","year":"2012","unstructured":"Ginsberg\u00a0D et\u00a0al (2012) Phase\u00a03 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic dertusor overaktivity. J\u00a0Urol 187(6):2131\u20132121","journal-title":"J Urol"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-024-02508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-024-02508-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-024-02508-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T22:10:17Z","timestamp":1739571017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-024-02508-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2508"],"URL":"https:\/\/doi.org\/10.1007\/s00120-024-02508-y","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"type":"print","value":"2731-7064"},{"type":"electronic","value":"2731-7072"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"13 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.C.\u00a0Kn\u00fcpfer gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}